Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet

Atherosclerosis

Volumn 192, Issue 2, 2007, Pages 335-341

  Blanco Colio, Luis Miguel ^a   Muñoz García, Begoña ^a   Martín Ventura, Jose Luis ^a   Alvarez Sala, Luis Antonio ^b   Castilla, Manuela ^b   Bustamante, Ana ^b   Lamuela Raventós, Rosa María ^c   Gómez Gerique, Juan ^a   Fernández Cruz, Arturo ^d   Millán, Jesús ^b   Egido, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Hospital Clinico   (Spain)

Author keywords

Fat enriched diet; Inflammation; MCP 1; NF kappaB; Red wine

Indexed keywords

ALCOHOL; CHEMOATTRACTANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYPHENOL;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BEVERAGE; BLOOD SAMPLING; BRANDY; CARDIOVASCULAR SYSTEM; DRUG ACTIVATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; LIPID DIET; MALE; MONOCYTE; MORTALITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RED WINE; RUM; VODKA; VOLUNTEER;

ADULT; ALCOHOLIC BEVERAGES; ANTI-INFLAMMATORY AGENTS; CHEMOKINE CCL2; DIETARY FATS; FEMALE; FLAVONOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; NF-KAPPA B; PHENOLS;

EID: 34248207187     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.07.035     Document Type: Article

References (34)

1. Klatsky A.L., Armstrong M.A., and Friedman G.D. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and non-drinkers. Am J Cardiol 58 (1986) 710-714
2. Friedman L.A., and Kimball A.W. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol 124 (1986) 481-489
3. Gaziano J.M., Buring J.E., Breslow J.L., et al. Moderate alcohol intake increased levels of high-density lipoprotein and its subfractions and decreased risk of myocardial infarction. N Engl J Med 329 (1993) 1829-1834
4. Renaud S., and de Lorgeril M. Wine alcohol, platelets and the French paradox. Lancet 339 (1992) 1523-1526
5. Mukamal K.J., Conigrave K.M., Mittleman M.A., et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 348 (2003) 109-118
6. Hayek T., Fuhrman B., Vaya J., et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 17 (1997) 2744-2752
7. Grimm S., and Baeuerle P.A. The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem J 290 (1993) 208-297
8. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben-Neriah Y., and Baeuerle P.A. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365 (1993) 182-185
9. de Winther M.P., Kanters E., Kraal G., and Hofker M.H. Nuclear factor kappa B signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25 (2005) 904-914
10. Lee J.I., and Burckart G.J. Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol 38 (1998) 981-993
11. Schreck R., Meier B., Mannel D.N., Droge W., and Bauerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 175 (1992) 1181-1194
12. Bustos C., Hernandez-Presa M.A., Ortego M., et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 32 (1998) 2057-2064
13. Brand K., Page S., Rogler G., et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97 (1996) 1715-1722
14. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88 (1991) 5252-5256
15. Matsumori A., Furukawa Y., Hashimoto T., et al. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 29 (1997) 419-423
16. Cipollone F., Marini M., Fazia M., et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 21 (2001) 327-334
17. Blanco-Colio L.M., Valderrama M., Alvarez-Sala L.A., et al. Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation 102 (2000) 1020-1026
18. Swain T., and Hillis W.E. The phenolic constituents of Pruunus domestica. J Sci Food Agric 10 (1969) 63-68
19. Fontanals-Ferrer N., Serrat-Serrat J., Sorribas-Vivas A., Gonzalez-García C., Gonzalez-Sastre F., and Gómez-Gerique J. Quick method of determining lipoproteins, including those of intermediate density, in serum. Clin Chem 34 (1998) 1753-1757
20. Martin-Ventura J.L., Blanco-Colio L.M., Munoz-Garcia B., et al. NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability. Stroke 35 (2004) 458-463
21. Ritchie M.E. Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 98 (1998) 1707-1713
22. Hernandez-Presa M.A., Ortego M., Tunon J., et al. Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet. Cardiovasc Res 57 (2003) 168-177
23. Muntwyler J., Hennekens C.H., Buring J.E., and Gaziano J.M. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet 352 (1998) 1882-1885
24. de Lorgeril M., and Salen P. Is alcohol anti-inflammatory in the context of coronary heart disease?. Heart 90 (2004) 355-357
25. Feng A.N., Chen Y.L., Chen Y.T., Ding Y.Z., and Lin S.J. Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-fed rabbits. Circulation 100 (1999) 2254-2259
26. Wang Z., Zou J., Cao K., Hsieh T.C., Huang Y., and Wu J.M. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med 16 (2005) 533-540
27. Stocker R., and O'Halloran M.A. Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the arterial wall. Am J Clin Nutr 79 (2004) 123-130
28. Deo R., Khera A., McGuire D.K., et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 44 (2004) 1812-1818
29. Sacanella E., and Estruch R. The effect of alcohol consumption on endothelial adhesion molecule expression. Addict Biol 8 (2003) 371-378
30. Estruch R., Sacanella E., Badia E., et al. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 175 (2004) 117-123
31. Rimm E.B., Williams P., Fosher K., Criqui M., and Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319 (1999) 1523-1528
32. Mukamal K.J., Cushman M., Mittleman M.A., Tracy R.P., and Siscovick D.S. Alcohol consumption and inflammatory markers in older adults: the Cardiovascular Health Study. Atherosclerosis 173 (2004) 79-87
33. Albert M.A., Glynn R.J., and Ridker P.M. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 107 (2003) 443-447
34. Di Castelnuovo A., Rotondo S., Lacoviello L., Donati M.B., and Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 105 (2002) 2836-2844